View Item 

Show simple item record

Referrals for suspected hematologic malignancy: A survey of primary care physicians

dc.contributor.authorAbel, Gregory A.en_US
dc.contributor.authorFriese, Christopher R.en_US
dc.contributor.authorNeville, Bridget A.en_US
dc.contributor.authorWilson, Katherine M.en_US
dc.contributor.authorHastings, B. Tayloren_US
dc.contributor.authorEarle, Craig C.en_US
dc.contributor.authorKeating, Nancy L.en_US
dc.contributor.authorRichardson, Lisa C.en_US
dc.date.accessioned2012-06-15T14:33:25Z
dc.date.available2013-08-01T14:04:39Zen_US
dc.date.issued2012-06en_US
dc.identifier.citationAbel, Gregory A.; Friese, Christopher R.; Neville, Bridget A.; Wilson, Katherine M.; Hastings, B. Taylor; Earle, Craig C.; Keating, Nancy L.; Richardson, Lisa C. (2012). "Referrals for suspected hematologic malignancy: A survey of primary care physicians ." American Journal of Hematology 87(6): 634-636. <http://hdl.handle.net/2027.42/91356>en_US
dc.identifier.issn0361-8609en_US
dc.identifier.issn1096-8652en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/91356
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.titleReferrals for suspected hematologic malignancy: A survey of primary care physiciansen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan School of Nursing, Ann Arbor, Michiganen_US
dc.contributor.affiliationumUniversity of Michigan School of Nursing, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherDana‐Farber Cancer Institute, 450 Brookline Avenue, Dana 1108, Boston, MA 02215en_US
dc.contributor.affiliationotherDivision of Population Sciences, Department of Medical Oncology, Dana‐Farber Cancer Institute, Boston, Massachusettsen_US
dc.contributor.affiliationotherCenter for Leukemia, Department of Medical Oncology, Dana‐Farber Cancer Institute, Boston, Massachusettsen_US
dc.contributor.affiliationotherDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgiaen_US
dc.contributor.affiliationotherInstitute for Clinical Evaluative Sciences, Sunnybrook Health Sciences Centre, Toronto, Ontarioen_US
dc.contributor.affiliationotherDivision of General Internal Medicine, Brigham and Women's Hospital and Department of Health Care Policy, Harvard Medical School, Boston, Massachusettsen_US
dc.contributor.affiliationotherDivision of Population Sciences, Department of Medical Oncology, Dana‐Farber Cancer Institute, Boston, Massachusettsen_US
dc.contributor.affiliationotherCenter for Leukemia, Department of Medical Oncology, Dana‐Farber Cancer Institute, Boston, Massachusettsen_US
dc.contributor.affiliationotherDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgiaen_US
dc.contributor.affiliationotherInstitute for Clinical Evaluative Sciences, Sunnybrook Health Sciences Centre, Toronto, Ontarioen_US
dc.contributor.affiliationotherDivision of General Internal Medicine, Brigham and Women's Hospital and Department of Health Care Policy, Harvard Medical School, Boston, Massachusettsen_US
dc.identifier.pmid22473854en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/91356/1/23172_ftp.pdf
dc.identifier.doi10.1002/ajh.23172en_US
dc.identifier.sourceAmerican Journal of Hematologyen_US
dc.identifier.citedreferenceMcConnell D, Butow PN, Tattersall MH. Improving the letters we write: An exploration of doctor‐doctor communication in cancer care. Br J Cancer 1999; 80: 427 – 437.en_US
dc.identifier.citedreferenceO'Malley AS, Reschovsky JD. Referral and consultation communication between primary care and specialist physicians: Finding common ground. Arch Intern Med 2011; 171: 56 – 65.en_US
dc.identifier.citedreferenceFriese CR, Abel GA, Magazu LS, et al. Diagnostic delay and complications for older adults with multiple myeloma. Leuk Lymphoma 2009; 50: 392 – 400.en_US
dc.identifier.citedreferenceMa X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes: Incidence and survival in the United States. Cancer 2007; 109: 1536 – 1542.en_US
dc.identifier.citedreferenceHowlader N NA, Krapcho M, Neyman N, et al, editors. SEER Cancer Statistics Review, 1975‐2008. National Cancer Institute: Bethesda, MD; 2011.en_US
dc.identifier.citedreferencePinilla‐Ibarz J, McQuary A. Chronic lymphocytic leukemia: Putting new treatment options into perspective. Cancer Control 2010; 17: 4 – 15; quiz 16.en_US
dc.identifier.citedreferenceKobayashi Y. Recent advances in the treatment of follicular lymphoma. Int J Clin Oncol 2009; 14: 191 – 196.en_US
dc.identifier.citedreferenceBurt RW. Colorectal cancer screening. Curr Opin Gastroenterol 2010; 26: 466 – 470.en_US
dc.identifier.citedreferenceGregory KD, Sawaya GF. Updated recommendations for breast cancer screening. Curr Opin Obstet Gynecol 2010; 22: 498 – 505.en_US
dc.identifier.citedreferenceSciarra A, Cattarino S, Gentilucci A, et al. Update on screening in prostate cancer based on recent clinical trials. Rev Recent Clin Trials 2011; 6: 7 – 15.en_US
dc.identifier.citedreferenceSmith RA, Cokkinides V, Brooks D, et al. Cancer screening in the United States, 2010: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2010; 60: 99 – 119.en_US
dc.identifier.citedreferenceAbel GA, Friese CR, Magazu LS, et al. Delays in referral and diagnosis for chronic hematologic malignancies: A literature review. Leuk Lymphoma 2008; 49: 1352 – 1359.en_US
dc.identifier.citedreferenceJones R, Latinovic R, Charlton J, Gulliford MC. Alarm symptoms in early diagnosis of cancer in primary care: Cohort study using General Practice Research Database. BMJ 2007; 334: 1040.en_US
dc.identifier.citedreferenceNekhlyudov L, Latosinsky S. The interface of primary and oncology specialty care: From symptoms to diagnosis. J Natl Cancer Inst Monogr 2010; 40: 11 – 17.en_US
dc.identifier.citedreferenceAnargyrou K, Vassilakopoulos TP, Angelopoulou MK, Terpos E. Incorporating novel agents in the treatment of myelodysplastic syndromes. Leuk Res 2010; 34: 6 – 17.en_US
dc.identifier.citedreferenceKumar S. Treatment of newly diagnosed multiple myeloma: Advances in current therapy. Med Oncol 2010; 27 ( Suppl 1 ): S14 – S24.en_US
dc.identifier.citedreferenceGroves R, Fowler F, Couper M, et al. Survey Methodology. Hoboken, NJ: Wiley‐Interscience; 2004.en_US
dc.identifier.citedreferenceWeisberg H KJ, Bowen B. An Introduction to Survey Research, Polling, and Data Analysis. Thousand Oaks: CA Sage Publications; 1996.en_US
dc.identifier.citedreferenceMartins Y, Lederman R, Lowenstein C, et al. Increasing response rates from physicians in oncology research: A structured literature review and data from a recent physician survey. Br J Cancer, 2012. Prepublished on 2012/03/01 as DOI bjc201228 [pii] 10.1038/bjc.2012.28 [doi].en_US
dc.identifier.citedreferenceAsch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997; 50: 1129 – 1136.en_US
dc.identifier.citedreferenceEpstein RM. Communication between primary care physicians and consultants. Arch Fam Med 1995; 4: 403 – 409.en_US
dc.identifier.citedreferenceAgency for Healthcare Research and Quality. Consumer Assessment of Healthcare Providers and Systems Survey 3.0 (CAHPS). Agency for Healthcare Research and Quality: Rockville, MD; 2006.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
23172_ftp.pdf
Size:
71.17KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.